{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-017006","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2025-04-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.225656+00:00","generated_at":"2026-05-23T18:58:13.637374+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"SANUWAVE Health reports preliminary Q1 2025 revenue of $9.1M-$9.3M, up 57-61% YoY","bullets":["Preliminary Q1 2025 revenue $9.1M-$9.3M, highest Q1 in company history; +57-61% vs Q1 2024.","UltraMIST revenue up >65% YoY, constitutes ~99% of total revenues.","Results slightly above upper end of guidance given in Q4 2024 earnings release (March 21, 2025).","CEO Morgan Frank notes sales force restructuring complete; all manufacturing domestic, no significant tariff impact.","Full Q1 2025 results expected around May 9, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-017006","json":"https://secwatch.observer/filing/0001628280-25-017006.json","markdown":"https://secwatch.observer/filing/0001628280-25-017006.md","text":"https://secwatch.observer/filing/0001628280-25-017006.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000162828025017006/0001628280-25-017006-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000162828025017006/snwv-20250408.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T18:58:13.637374+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}